Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Research article

Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis

Authors: Ahmed Elmaraezy, Ammar Ismail, Abdelrahman Ibrahim Abushouk, Moutaz Eltoomy, Soha Saad, Ahmed Negida, Osama Mahmoud Abdelaty, Ahmed Ramadan Abdallah, Ahmed Magdy Aboelfotoh, Hossam Mahmoud Hassan, Aya Gamal Elmaraezy, Mahmoud Morsi, Farah Althaher, Moath Althaher, Ammar M. AlSafadi

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

Recently, transcatheter aortic valve replacement (TAVR) has become the procedure of choice in high surgical risk patients with aortic stenosis (AS). However, its value is still debated in operable AS cases. We performed this meta-analysis to compare the safety and efficacy of TAVR to surgical aortic valve replacement (SAVR) in low-to-moderate surgical risk patients with AS.

Methods

A systematic search of five authentic databases retrieved 11 eligible studies (20,056 patients). Relevant Data were pooled as risk ratios (RRs) or standardized mean differences (SMD), with their 95% confidence interval, using Comprehensive Meta-Analysis and RevMan software for windows.

Results

At one-year of follow-up, the pooled effect-estimates showed no significant difference between TAVR and SAVR groups in terms of all-cause mortality (RR 1.02, 95% CI [0.83, 1.26], stroke (RR 0.83, 95%CI [0.56, 1.21]), myocardial infarction (RR 0.82, 95% CI [0.57, 1.19]), and length of hospital stay (SMD -0.04, 95% CI [−0.34, 0.26]). The incidence of major bleeding (RR 0.45, 95% CI [0.24, 0.86]) and acute kidney injury (RR 0.52, 95% CI [0.30, 0.88]) was significantly lower in the TAVR group, compared to the SAVR group. However, TAVR was associated with a higher risk of permanent pacemaker implantation (RR 2.57, 95% CI [1.36, 4.86]), vascular-access complications at 1 year (RR 1.99, 95%CI [1.04, 3.80]), and paravalvular aortic regurgitation at 30 days (RR 3.90, 95% CI [1.25, 12.12]), compared to SAVR.

Conclusions

Due to the comparable mortality rates in SAVR and TAVR groups and the lower risk of life-threatening complications in the TAVR group, TAVR can be an acceptable alternative to SAVR in low-to-moderate risk patients with AS. However, larger trials with longer follow-up periods are required to compare the long-term outcomes of both techniques.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–5.CrossRefPubMed Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–5.CrossRefPubMed
2.
go back to reference Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.CrossRefPubMed Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.CrossRefPubMed
3.
go back to reference Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002–12.CrossRefPubMed Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002–12.CrossRefPubMed
4.
go back to reference Cribier A, Durand E, Eltchaninoff H. Patient selection for TAVI in 2014: is it justified to treat low-or intermediate-risk patients? The cardiologist’s view. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014;10:U16–21.CrossRef Cribier A, Durand E, Eltchaninoff H. Patient selection for TAVI in 2014: is it justified to treat low-or intermediate-risk patients? The cardiologist’s view. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014;10:U16–21.CrossRef
5.
go back to reference Oguri A, Yamamoto M, Mouillet G, et al. Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia. Circulation: Cardiovascular Interventions. 2014;7:602–10. Oguri A, Yamamoto M, Mouillet G, et al. Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia. Circulation: Cardiovascular Interventions. 2014;7:602–10.
6.
go back to reference Rees CM, Eric HO. Should patients with low-moderate surgical risk be offered TAVI instead of conventional aortic valve replacement in the management of symptomatic aortic stenosis? Res Medica. 2015;23:15–21.CrossRef Rees CM, Eric HO. Should patients with low-moderate surgical risk be offered TAVI instead of conventional aortic valve replacement in the management of symptomatic aortic stenosis? Res Medica. 2015;23:15–21.CrossRef
7.
go back to reference Tamburino C, Barbanti M, D’Errigo P, et al. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT study. J Am Coll Cardiol. 2015;66:804–12.CrossRefPubMed Tamburino C, Barbanti M, D’Errigo P, et al. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT study. J Am Coll Cardiol. 2015;66:804–12.CrossRefPubMed
8.
go back to reference Martin B. Leon, M.D. CR et cols (2016) Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 374:1609–1620. doi: 10.1056/NEJMoa1514616. Martin B. Leon, M.D. CR et cols (2016) Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 374:1609–1620. doi: 10.​1056/​NEJMoa1514616.
9.
go back to reference Thyregod HGH, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94. doi: 10.1016/j.jacc.2015.03.014.CrossRefPubMed Thyregod HGH, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94. doi: 10.​1016/​j.​jacc.​2015.​03.​014.CrossRefPubMed
11.
go back to reference Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383–9. doi: 10.4244/eijv8i3a58.CrossRefPubMed Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383–9. doi: 10.​4244/​eijv8i3a58.CrossRefPubMed
12.
go back to reference D’Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol. 2013;167:1945–52.CrossRefPubMed D’Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol. 2013;167:1945–52.CrossRefPubMed
13.
go back to reference Higgins JP, Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. doi: 10.1002/9780470712184. Higgins JP, Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. doi: 10.​1002/​9780470712184.
15.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5. doi: 10.1056/NEJMoa1400590. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5. doi: 10.​1056/​NEJMoa1400590.
16.
go back to reference Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997;315:629–34.CrossRef Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997;315:629–34.CrossRef
18.
go back to reference Castrodeza J, Amat-Santos IJ, Blanco M, et al. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients: A hint of real-world. Cardiology Journal. 2016;23:541–51. doi: 10.5603/CJ.a2016.0051.PubMed Castrodeza J, Amat-Santos IJ, Blanco M, et al. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients: A hint of real-world. Cardiology Journal. 2016;23:541–51. doi: 10.​5603/​CJ.​a2016.​0051.PubMed
19.
go back to reference Latib A, Maisano F, Bertoldi L, et al. Transcatheter vs surgical aortic valve replacement in intermediate- surgical-risk patients with aortic stenosis: A propensity score-matched case-control study. Am Heart J. 2012;164:910–7. doi: 10.1016/j.ahj.2012.09.005.CrossRefPubMed Latib A, Maisano F, Bertoldi L, et al. Transcatheter vs surgical aortic valve replacement in intermediate- surgical-risk patients with aortic stenosis: A propensity score-matched case-control study. Am Heart J. 2012;164:910–7. doi: 10.​1016/​j.​ahj.​2012.​09.​005.CrossRefPubMed
20.
go back to reference Möllmann H, Bestehorn K, Bestehorn M, et al. In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol. 2016;105:553–9. doi: 10.1007/s00392-016-0962-4.CrossRefPubMed Möllmann H, Bestehorn K, Bestehorn M, et al. In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol. 2016;105:553–9. doi: 10.​1007/​s00392-016-0962-4.CrossRefPubMed
22.
go back to reference Piazza N, Kalesan B, Van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. J Am Coll Cardiol Intv. 2013;6:443–51. doi: 10.1016/j.jcin.2013.01.136.CrossRef Piazza N, Kalesan B, Van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. J Am Coll Cardiol Intv. 2013;6:443–51. doi: 10.​1016/​j.​jcin.​2013.​01.​136.CrossRef
23.
24.
go back to reference Schymik G, Heimeshoff M, Bramlage P, et al. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk. Catheter Cardiovasc Interv. 2015;86:738–44. doi: 10.1002/ccd.25866.CrossRefPubMed Schymik G, Heimeshoff M, Bramlage P, et al. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk. Catheter Cardiovasc Interv. 2015;86:738–44. doi: 10.​1002/​ccd.​25866.CrossRefPubMed
25.
go back to reference Søndergaard L, Steinbrüchel DA, Ihlemann N, et al. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement. Circulation: Cardiovascular Interventions. 2016;9(6):e003665. Søndergaard L, Steinbrüchel DA, Ihlemann N, et al. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement. Circulation: Cardiovascular Interventions. 2016;9(6):e003665.
26.
go back to reference Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation. 2002;106:3006–8.CrossRefPubMed Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation. 2002;106:3006–8.CrossRefPubMed
27.
go back to reference Nishimura RA, Otto CM, Bonow RO, et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease. Circulation 129:CIR. 0000000000000031. Nishimura RA, Otto CM, Bonow RO, et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease. Circulation 129:CIR. 0000000000000031.
28.
go back to reference Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). G Ital Cardiol (2006). 2013;14:167–214. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). G Ital Cardiol (2006). 2013;14:167–214.
29.
go back to reference Nishimura RA, Otto CM, Bonow RO, et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology CIR.0000000000000503. Nishimura RA, Otto CM, Bonow RO, et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology CIR.0000000000000503.
30.
go back to reference Détaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation: impact of device and annulus discongruence. J Am Coll Cardiol Intv. 2009;2:821–7.CrossRef Détaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation: impact of device and annulus discongruence. J Am Coll Cardiol Intv. 2009;2:821–7.CrossRef
31.
go back to reference Kondur A, Briasoulis A, Palla M, et al. Meta-analysis of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with severe aortic valve stenosis. Am J Cardiol. 2016;117:252–7.CrossRefPubMed Kondur A, Briasoulis A, Palla M, et al. Meta-analysis of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with severe aortic valve stenosis. Am J Cardiol. 2016;117:252–7.CrossRefPubMed
32.
go back to reference Mylotte D, Dorfmeister M, Elhmidi Y, et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. J Am Coll Cardiol Intv. 2014;7:652–61.CrossRef Mylotte D, Dorfmeister M, Elhmidi Y, et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. J Am Coll Cardiol Intv. 2014;7:652–61.CrossRef
33.
go back to reference Leipsic J, Gurvitch R, LaBounty TM, et al. Multidetector computed tomography in transcatheter aortic valve implantation. J Am Coll Cardiol Img. 2011;4:416–29.CrossRef Leipsic J, Gurvitch R, LaBounty TM, et al. Multidetector computed tomography in transcatheter aortic valve implantation. J Am Coll Cardiol Img. 2011;4:416–29.CrossRef
34.
go back to reference Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). Journal of cardiovascular computed tomography. 2012;6:366–80.CrossRefPubMed Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). Journal of cardiovascular computed tomography. 2012;6:366–80.CrossRefPubMed
35.
go back to reference Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28.CrossRefPubMed Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28.CrossRefPubMed
36.
go back to reference Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. J Am Coll Cardiol Intv. 2011;4:743–50.CrossRef Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. J Am Coll Cardiol Intv. 2011;4:743–50.CrossRef
37.
go back to reference Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.CrossRefPubMed Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.CrossRefPubMed
38.
go back to reference Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J. 2008;30:74–80.CrossRefPubMed Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J. 2008;30:74–80.CrossRefPubMed
39.
go back to reference Wendt D, Osswald BR, Kayser K, et al. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg. 2009;88:468–75.CrossRefPubMed Wendt D, Osswald BR, Kayser K, et al. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg. 2009;88:468–75.CrossRefPubMed
40.
go back to reference Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare event studies: The Rosiglitazone link with myocardial infarction and cardiac death. Stat Med. 2007;26:4375–85.CrossRefPubMed Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare event studies: The Rosiglitazone link with myocardial infarction and cardiac death. Stat Med. 2007;26:4375–85.CrossRefPubMed
Metadata
Title
Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis
Authors
Ahmed Elmaraezy
Ammar Ismail
Abdelrahman Ibrahim Abushouk
Moutaz Eltoomy
Soha Saad
Ahmed Negida
Osama Mahmoud Abdelaty
Ahmed Ramadan Abdallah
Ahmed Magdy Aboelfotoh
Hossam Mahmoud Hassan
Aya Gamal Elmaraezy
Mahmoud Morsi
Farah Althaher
Moath Althaher
Ammar M. AlSafadi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0668-1

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue